On March 10, 2023, Erika L. Eves, Vice President, Finance and Administration, Principal Financial Officer and Principal Accounting Officer of Navidea Biopharmaceuticals, Inc. (the “Company”), informed the Company of her resignation. Ms. Eves' last day of employment with the Company will be March 31, 2023.
On March 16, 2023 the Company's Board of Directors (the “Board”) designated Joseph W. Meyer as the Company's Principal Financial Officer and Principal Accounting Officer, effective upon Ms. Eves' departure from the Company. Mr. Meyer, age 35, has served as Controller of the Company since April 2022. Mr. Meyer also served as the Company's Accounting Manager from March 2017 to March 2022. Mr. Meyer holds a B.B.A. from Ohio University College of Business.